In cystic fibrosis (CF), certain immune cells show signs of dysfunction very early in life, according to a new…
Articles by Marisa Wexler, MS
Registration is now open for BreatheCon 2025, an annual online event hosted by the Cystic Fibrosis Foundation that…
A new triple-combination CFTR modulator therapy — vanzacaftor, tezacaftor, and deutivacaftor — has been approved by the U.S. Food and…
Infection with an airway bacterium called Haemophilus influenzae isn’t linked with worse lung health outcomes among adults with cystic…
A young man with cystic fibrosis (CF) successfully underwent a heart transplant, according to a first-of-its kind report described…
The Cystic Fibrosis Foundation is investing up to $15 million in Recode Therapeutics to help spur the development…
A Phase 1/2 clinical trial testing the inhaled gene therapy SP-101 in adults with cystic fibrosis (CF) has begun…
Researchers have created a new technology to measure the thickness of mucus in the airways, which could aid in monitoring…
Bonnie Ramsey, MD, a pediatrician and researcher who dedicated her career to advancing care for cystic fibrosis (CF), has…
The cystic fibrosis (CF) treatment Trikafta leads to changes in airway cell gene expression, or activity, that may…